Title FDA, Merck, and Vioxx : putting patient safety first? : hearing before the Committee on Finance, United States Senate, One Hundred Eighth Congress, second session ; November 18, 2004

Published Buffalo, N.Y. : William S. Hein & Co., 2012

Click on the following:
Hein Online books

Copies

Description 1 online resource (iv, 971 pages) : illustrations Series Hein's electronic documents reprint series ; title 33 United States. Congress. Senate. S. hrg. ; 108-791. Hein's electronic documents reprint series ; title 33. Notes Originally published: Washington : U.S.G.P.O., 2005 (S. hrg.; 108-791); withdrawn from the federal depository library program 6/20/06 per GPO request Bibliography Includes bibliographical references Notes Print version record Subject Merck & Co. -- Corrupt practices SUBJECT Merck & Co. fast (OCoLC)fst00559439 Subject Rofecoxib. Drug monitoring -- United States Drugs -- United States -- Testing Corruption. Drug monitoring. Drugs -- Testing. Rofecoxib. United States. Form Electronic book

Other Titles Hearing before the Committee on Finance, United States Senate, One Hundred and Eighth Congress, second session; November 18, 2004 Putting patient safety first? Food and Drug Administration, Merck, and Vioxx

  Permalink